Preclinical studies have shown that BCL-2 is frequently overexpressed in AML blasts, compared to their normal hematopoietic counterpart and BCL-2 levels are particularly high in progenitor/stem leukemic cells [79,80]. Here, BCL2 is linked to acute myeloid leukemia.